Mail

UK markets closed

FTSE 100
6,630.52
-20.36(-0.31%)
FTSE 250
20,961.31
-334.92(-1.57%)
AIM
1,163.26
-10.13(-0.86%)

UK government unveils 'Declaration to Travel' permits for outbound travellers

Those who fail to comply face a £200 fine which can soar to a maximum of £6,400

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

69.00-0.56 (-0.81%)

At close: 4:00PM EST

Currency in USD

Earnings estimate	Current qtr. (Mar 2021)	Next qtr. (Jun 2021)	Current year (2021)	Next year (2022)
No. of analysts	10	9	10	12
Avg. Estimate	-0.13	-0.2	-0.55	-0.64
Low estimate	-0.38	-0.4	-1.16	-2.3
High estimate	0.01	-0.01	1.86	1.31
Year ago EPS	-0.2	-0.13	-0.84	-0.55

Revenue estimate	Current qtr. (Mar 2021)	Next qtr. (Jun 2021)	Current year (2021)	Next year (2022)
No. of analysts	8	8	8	10
Avg. Estimate	37.7M	35.49M	137.33M	219.67M
Low estimate	11.68M	11.21M	81.3M	74.56M
High estimate	55.7M	58.9M	198.2M	390.4M
Year ago sales	N/A	N/A	87.99M	137.33M
Sales growth (year/est)	N/A	N/A	56.10%	60.00%

Earnings history	30/03/2020	29/06/2020	29/09/2020	30/12/2020
Est. EPS	-0.11	-0.12	0.12	0.12
Actual EPS	-0.2	-0.13	-0.48	-0.2
Difference	-0.09	-0.01	-0.6	-0.32
Surprise %	-81.80%	-8.30%	-500.00%	-266.70%

EPS trend	Current qtr. (Mar 2021)	Next qtr. (Jun 2021)	Current year (2021)	Next year (2022)
Current estimate	-0.13	-0.2	-0.55	-0.64
7 days ago	-0.13	-0.2	-0.55	-0.64
30 days ago	-0.27	-0.32	-0.23	-1.12
60 days ago	-0.25	-0.29	-0.24	-0.92
90 days ago	-0.25	-0.31	-0.39	-0.86

EPS revisions	Current qtr. (Mar 2021)	Next qtr. (Jun 2021)	Current year (2021)	Next year (2022)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	10	8	8	7
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	ARWR	Industry	Sector(s)	S&P 500
Current qtr.	35.00%	N/A	N/A	N/A
Next qtr.	-53.80%	N/A	N/A	N/A
Current year	34.50%	N/A	N/A	N/A
Next year	-16.40%	N/A	N/A	N/A
Next 5 years (per annum)	7.33%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A